Why the CDC Has Recommended New Covid Boosters for All

As covid-19 hospitalizations tick upward with fall approaching, the CDC says it’s time for new boosters — and not only for those at highest risk of serious disease. Here are seven things you need to know.

The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers

The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer’s, experts say.

Mammograms at 40? Breast Cancer Screening Guidelines Spark Fresh Debate

There is no direct evidence that screening women in their 40s will save lives, yet modeling suggests expanding routine mammography to include them might avert 1.3 deaths per 1,000. Highlighting the risk of false positives, some specialists call for a more personalized approach.

¿Mamografías a los 40? Nueva pauta para la detección del cáncer de seno genera debate

Algunos médicos e investigadores que están interesados en un enfoque más individualizado para encontrar tumores problemáticos se muestran escépticos y plantean preguntas sobre los datos y el razonamiento detrás del cambio radical del Grupo de Trabajo de Servicios Preventivos de Estados Unidos

A Covid Test Medicare Scam May Be a Trial Run for Further Fraud

Before the covid-19 public health emergency ended, Medicare advocates around the country noticed a rise in complaints from beneficiaries who received at-home covid tests they never requested. Bad actors may have used seniors’ Medicare information to improperly bill the federal government — and could do it again, say federal investigators.